Elixir Energy (EXR.AX): Imminent Catalysts and a 50% Peer Discount
Elixir Energy (EXR.AX) has expanded its booked contingent resources by 24% to 3,455 BCFe, lifting its intrinsic baseline. Near‑term de‑risking events include the Xstate Diona‑1 well test in April and Elixir’s Lorelle‑3 horizontal test in June. The company’s market cap of roughly AUD 300 million (≈ $198 million USD) trades at about a 50% discount to the average E&P peer for undeveloped assets. Insider buying, government‑backed regulatory easing, and a persistent gas deficit in Eastern Australia provide strong macro tailwinds.
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
Quanterix Corporation announced it will release its first‑quarter 2026 financial results after the market closes on May 6, 2026, followed by a conference call at 4:30 p.m. ET. The press release and live webcast will be posted on the company’s investor relations site,...
Aluula Composites ($AUUA.V) FINS Review
Aluula Composites (AUUA.V) is a micro‑cap maker of ultra‑light, recyclable composite fabrics used by top performance brands. The company’s market value sits around $90 million after a dramatic 9‑times rally from January to June last year, followed by a 48% decline...
Opportunity: April 2026
The April 2026 Opportunity Report spotlights a niche firm that outperforms peers in a rapidly expanding market. The company boasts gross margins above 60%, capex under 1% of sales, and a net‑cash balance sheet. Its founders retain over 40% ownership...
The IPO Buzz: X-Energy (XE) Upsizes IPO & Prices It at $23 – $4 Above Range
X-Energy (XE) upsized its IPO to 44.25 million shares and priced the offering at $23 per share, $4 above the top of the $16‑$19 range, raising roughly $1.02 billion. The stock opened at $30.11 and closed the first trading day at $29.20,...
NeurAxis (NRXS): The Pieces Are Lining Up
NeurAxis (NRXS) released preliminary Q1 data showing the first full quarter under the new Category I CPT code and expanded insurance coverage that took effect at the end of 2025. The results exceeded the analyst’s expectations, prompting a renewed bullish stance...
Inventurus Knowledge Solutions Acquires TruBridge for $557.27 Million
Inventurus Knowledge Solutions announced an all‑cash acquisition of TruBridge for $557.27 million, pricing each share at $26.25—a 14.83% premium to the prior close. The transaction, slated to close in Q3 2026, will be funded mainly through new debt arranged by Citibank, JPMorgan...
The IPO Buzz: The Elmet Group (ELMT) Upsizes IPO & Prices It at $14 – Top of Range
The Elmet Group (ELMT) upsized its IPO to 8.6 million shares and priced the offering at $14, the top of its $12‑$14 range, raising roughly $120.4 million. The pricing gave the company a market capitalization of about $411.6 million. On its Nasdaq debut,...
Quick and Timely Idea: Positioned for a Sale
The firm announced a strategic alternatives review after previously turning down a private‑equity buyout offer. The language of the release suggests the sale process is already well‑advanced, with analysts estimating an over‑80% chance of a transaction within the next three...
The IPO Buzz: Yesway (YSWY) Prices Upsized IPO at $20 – Low End – & Stock Opens at $22
Yesway (YSWY) priced its IPO at the low end of the $20‑$23 range, setting the price at $20 per share and upsizing the offering to 14 million shares, which raised roughly $280 million. The stock opened at $22, climbed to $22.60 intraday,...
Wed 22 Apr 2026 - Paul Scott's Small/Mid Cap Value Report
On April 22, 2026, equity analyst Paul Scott published his Small/Mid‑Cap Value Report, spotlighting TENG as the headline recommendation. The brief also lists 17 additional tickers—including RKT, ABDN, SNR, and SHOE—spanning sectors such as biotech, industrials, and consumer goods. Scott’s...
Small-Cap Mailbag: Cleanspace Holdings (ASX: CSX)
CleanSpace Holdings (ASX:CSX), an Australian maker of powered‑air‑purifying respirators, posted a paper profit of A$2.8 million in H1 FY2026 after extinguishing a liability, but would have recorded a loss of about A$1 million without it. Chairman Graham McLean recently bought roughly A$50k of...
9 Must-Buy Penny Stocks to Invest In Now
A tentative cease‑fire in the US‑Israel‑Iran conflict sparked a three‑week rally that lifted the Dow 1.8% and pushed the S&P 500 and Nasdaq to record highs, reviving optimism for small‑cap equities. Despite lingering geopolitical risk, analysts see the Russell 2000...
Intellia Therapeutics, Inc. (NTLA) Sees Moderate Buy Rating From Analysts
Intellia Therapeutics (NASDAQ:NTLA) earned a moderate buy rating from Wall Street analysts, who set an average price target of $21.25. The gene‑editing firm’s stock has climbed 88.76% over the past year and is up 62.32% year‑to‑date. In an SEC filing,...
Compass Therapeutics, Inc. (CMPX) Up 200% Year-on-Year
Compass Therapeutics (CMPX) has delivered a spectacular rally, climbing 237% over the past year and gaining 16% year‑to‑date. Analyst John Newman of Cannaccord Genuity reaffirmed a Buy rating with a $13 price target on April 7. CEO Thomas Schuetz highlighted that the...
Annexon Biosciences (ANNX) Buy Rating Retained
Annexon Biosciences (NASDAQ:ANNX) retained a Buy rating from Needham analyst Joseph Stringer, who set a new price target of $11. The small‑cap biotech has rallied 289.3% over the past year and is up 39.5% year‑to‑date. CEO Douglas Love highlighted progress...
Iron Horse Acquisition II Corp. (IRHO) to Combine with Electra Vehicles in $250M Deal
SPAC Iron Horse Acquisition II Corp. (ticker IRHO) announced a definitive merger agreement with Electra Vehicles, an electric‑vehicle technology firm. The transaction values the combined entity at approximately $250 million, with IRHO shareholders receiving a mix of cash and Electra shares....
Archimedes Tech SPAC Partners II Co. (ATII) to Combine with Forge Nano in $1.3Bn Deal
Archimedes Tech SPAC Partners II Co. (ATII) announced a definitive agreement to merge with nanotechnology firm Forge Nano, creating a combined public entity valued at approximately $1.3 billion. The transaction will deliver roughly $200 million in cash to Forge Nano and grant...
Weekly Update #11 - Week Ending 04/19/26
Medexus Pharmaceuticals reported that 56 U.S. transplant centers (31% of the market) now carry its GRAFAPEX drug, up from 46 in December, and the company still targets more than $100 million in peak annual revenue, which would halve its forward P/E...
Magna Mining Reports Fourth Quarter and Full Year 2025 Financial Results
Magna Mining Inc. posted Q4 2025 results showing a positive cash margin of C$3.3 million (≈US$2.4 million) at its McCreedy West mine and record quarterly output of 5.0 million copper‑equivalent pounds. Full‑year 2025 production reached 11.5 million CuEq lbs with cash costs of US$3.72 per lb and...
US Gold Corp (NASDAQ:USAU) – $1.4B NPV at Spot, Fully Permitted, Major Upside
U.S. Gold Corp. released a definitive feasibility study for its CK Gold project in Wyoming, showing an after‑tax NPV of $635 million and a 27% IRR at a $3,250/oz gold price. At current spot prices near $4,500/oz, the NPV jumps to...
Podcast: Inside Key Mining’s $303M Deal with Compass Digital Acquisition Corp. (CDAQF)
Key Mining Corp. announced a $303 million business combination with Compass Digital Acquisition Corp., a SPAC, to bring its titanium, copper and water‑desalination projects public. The deal merges a flagship titanium mine in Chile, a copper project in Arizona, and a...
Club Conversation with Paul Andreola, Buying & Riding 100 Baggers
Paul Andreola, founder of Small Cap Discoveries and CEO of NameSilo, sat down for a MicroCapClub conversation on investing in micro‑cap “100‑bagger” stocks. He outlined his evolving philosophy that blends rigorous due‑diligence, bias control, and relationship‑driven sourcing to find high‑growth...
Weekly Video (4/19/2026)
The weekly video released on April 19, 2026 focused on two junior gold miners, Andean Precious Metals and Artemis Gold. It highlighted Andean’s recent 30% boost in its resource estimate following a successful drilling program and Artemis’s $15 million financing round...
April WWW - What's Wolf Watching
The April edition of Wolf of Oakville’s newsletter signals a shift in the 2026 small‑cap earnings season, with Buy Zones now outnumbering Danger Zones two to one. The author highlights recent successes, including iFabric’s 86% jump since the last issue...
Operational Inflection + GLP-1 Winner
A low‑priced consumer business currently in a turnaround is hitting an operational inflection point, with GLP‑1 drug adoption expected to accelerate growth. The company trades at roughly 4.7 × EBITDA and holds net cash equal to about half its market capitalization, creating...
Frequentis FY 2025
The Substack post teases an analysis of Frequentis AG’s fiscal year 2025 outlook, suggesting there may still be upside potential for the Austrian air‑traffic communications specialist. While the article is behind a paywall, it hints at revenue growth, margin expansion,...
Decibel Cannabis Q4 FY25 Update – DB.v/ DBCCF
Decibel Cannabis reported Q4 FY25 revenue of CAD 28.7 million ($21 million USD), a 13% year‑over‑year increase, while full‑year revenue rose 22% to CAD 112.7 million ($83 million USD). International sales exploded, up 116% YoY to CAD 7.4 million ($5.5 million USD) in the quarter and representing 27% of...
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
RBC Capital trimmed its price target for Karyopharm Therapeutics (KPTI) to $16 from $23, citing short‑term seasonal pressures such as reimbursement resets, fewer selling days and weather‑related disruptions that could weigh on newly launched, clinic‑administered products. The brokerage kept an...
Evercore Maintains Positive Stance on MeiraGTx Holdings Plc (MGTX) Amid Sector Revisions
Evercore ISI analyst Gavin Clark‑Gartner lowered his price target for MeiraGTx Holdings (MGTX) from $20 to $18 while maintaining an Outperform rating, part of a sector‑wide revision of small‑ and mid‑cap biotech firms. The adjustment follows the FDA’s recent Breakthrough...
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
Jefferies lowered its price target for Arbutus Biopharma (ABUS) from $7.00 to $5.50 while keeping a Buy rating, citing a higher probability that Moderna will win its appeal in a patent dispute. The appeal outcome affects a potential $1.3 billion contingent...
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value
Mizuho Securities raised its price target on Corbus Pharmaceuticals (CRBP) to $40, maintaining an Outperform rating after the company’s fourth‑quarter results. The firm highlighted that CRBP is trading near its cash balance, which it says caps downside risk. Mizuho expects...
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
Jefferies downgraded Replimune Group (NASDAQ:REPL) from Buy to Hold and slashed its price target to $2 after the FDA issued a complete response letter on the RP1 oncolytic therapy. The FDA’s feedback diverged from earlier Type A meeting guidance, raising...
Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions
Evercore ISI trimmed Fortrea Holdings (FTRE) price target to $14 from $25 while keeping an Outperform rating, citing revised near‑term assumptions in its Q1 healthcare technology update. The change coincides with FTRE’s launch of Fortrea Intelligent Technology (FIT), an AI‑enabled...
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
Wolfe Research has initiated coverage of Palisade Bio (NASDAQ:PALI) with an Outperform rating and a $7 price target, signaling confidence in the company’s long‑term prospects despite limited near‑term activity. The firm highlighted Phase 1b data for the oral PDE4 prodrug PALI‑2108,...
The IPO Buzz: Alamar Biosciences (ALMR) Upsizes IPO & Prices It at $17 – High End
Alamar Biosciences (ALMR) upsized its IPO to 11.25 million shares and priced at the top of its range, $17 per share, raising about $191.25 million. The offering values the company at roughly $1.14 billion as it prepares to debut on Nasdaq on April 17....
JATT II Acquisition Corp. (JATT) Prices $60M IPO
JATT II Acquisition Corp. priced a $60 million initial public offering and will begin trading on Nasdaq under the ticker JATT on April 17, 2026. The SPAC is focused on acquiring a healthcare or life‑science company, with an emphasis on biotechnology. Led by...
Madison Air Must Have Inhaled
Madison Air (ticker MAIR) is an HVAC roll‑up that leans heavily on hype, branding its fan installations as a revolutionary "Return on Air" solution. Management claims a 15% boost in warehouse productivity and a 30% cut in energy costs after...
The Elmet Group (ELMT) IPO Deck
Elmet Group, an industrial‑technology firm that builds critical‑materials components and high‑power microwave systems, unveiled its IPO deck on April 16, 2026. The company is seeking roughly $500 million in new capital to expand manufacturing capacity and deepen its role in the U.S. critical‑components...
30% Levered FCF Yield but Bad Balance Sheet, Bad Business?
The company, a commodity‑focused firm, projects 2026 EBITDA of $160 million, essentially flat with its 2023 $162 million level, yet its market cap does not reflect this earnings power. Management expects cash flow and announced asset sales to repair a strained balance...
Turned Around Software Company in Play
A software firm with roughly $350 million market cap has completed a turnaround, posting GAAP profitability, positive free cash flow and a sticky recurring‑revenue base above 90%. The newly appointed board is exercising tight capital discipline, positioning the company as a...
Thu 16 Apr 2026 - Paul Scott's Small/Mid Cap Value Report
Paul Scott’s latest Small/Mid‑Cap Value Report spotlights a slate of 24 equities he deems undervalued, ranging from technology names like SAGA and ALU to industrial players such as MTO and MERC. The list spans multiple sectors and focuses on companies...
Aevex: Small Drones at Scale
Aevex (AVEX) is preparing a 16‑million‑share offering priced between $18 and $22 per share. The company posted Q1 2026 revenue of $200‑$208 million, a four‑fold year‑over‑year increase, and adjusted EBITDA of $33.5‑$36.4 million, reversing a prior‑year loss. Valuation multiples now sit near 2.6×...
New SPAC: FortuneX Acquisition Corporation (FXACU) Files for $75M IPO
FortuneX Acquisition Corporation (ticker FXACU) filed its S‑1 to raise up to $75 million in a new special purpose acquisition company (SPAC) IPO. The filing targets a Nasdaq listing and outlines a typical 24‑month acquisition window, with a focus on technology...
Watching A Potential Big Pharma Buyout
A seasoned trader has flagged a small‑cap biotech that checks the key boxes big pharma seeks in an acquisition: late‑stage clinical validation, an imminent FDA decision, a multi‑billion‑dollar addressable market, and a cash‑rich balance sheet. The company’s lead asset is...
Aixtron Raises 2026 Opto Revenue (Again)
Aixtron announced a preliminary 2026 full‑year revenue uplift, with virtually all the upside coming from its optoelectronic (opto) equipment division. The revision, posted in a brief earnings release, signals stronger demand for MOCVD tools used in LEDs, lasers and emerging...
Investcorp AI Acquisition Corp. (IVCA) to Combine with Blue Finance in $219M Deal
Investcorp AI Acquisition Corp. (IVCA) announced a definitive agreement to combine with Blue Finance, creating a public company valued at approximately $219 million. The transaction positions the new entity as an AI‑focused investment platform, leveraging IVCA’s SPAC structure and Blue Finance’s...
Sizzle Acquisition Corp. II (SZZL) to Combine with Trasteel Holding in $1.3Bn Deal
Sizzle Acquisition Corp. II (ticker SZZL) announced a definitive business combination with Trasteel Holding, a steel manufacturing and recycling company, in a transaction valued at roughly $1.3 billion. The agreement provides Trasteel with about $300 million in cash and the balance in...
Yesway (YSWY) IPO Deck
Yesway (ticker YSWY) released its initial public offering deck, showcasing a network of roughly 1,200 convenience stores that blend foodservice and grocery items for rural and suburban shoppers. The company reported FY2025 revenue of about $1.2 billion, reflecting a 9% year‑over‑year...
MachTen: A Mispriced Rural Fiber Infrastructure Play
MachTen Inc. (OTC:MACT) recently acquired AT&T’s wireline assets in Michigan’s Upper Peninsula, expanding its network by thousands of miles. The company is executing a $100 million fiber build‑out in northern Michigan, with roughly 75% of the cost covered by federal subsidies...